273 related articles for article (PubMed ID: 11219145)
1. [Effect of aldosterone antagonism in heart failure: pharmacotherapeutic options].
Diercks GF; Overdiek JW; van Veldhuisen DJ
Ned Tijdschr Geneeskd; 2001 Feb; 145(5):204-8. PubMed ID: 11219145
[TBL] [Abstract][Full Text] [Related]
2. Aldosterone antagonism in addition to angiotensin-converting enzyme inhibitors in heart failure.
Bauersachs J; Fraccarollo D
Minerva Cardioangiol; 2003 Apr; 51(2):155-64. PubMed ID: 12783071
[TBL] [Abstract][Full Text] [Related]
3. [Anti-aldosterone therapy in severe heart failure].
van Guldener C; Donker AJ
Ned Tijdschr Geneeskd; 1999 Aug; 143(34):1724-6. PubMed ID: 10494316
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotection by aldosterone receptor antagonism in heart failure. Part I. The role of aldosterone in heart failure.
Dieterich HA; Wendt C; Saborowski F
Fiziol Cheloveka; 2005; 31(6):97-105. PubMed ID: 16366159
[TBL] [Abstract][Full Text] [Related]
5. [Dangerous hyperkalemia as sequelae of new treatment strategies of heart failure].
Fuster D; Frey FJ; Ferrari P
Praxis (Bern 1994); 2000 Dec; 89(49):2073-6. PubMed ID: 11190849
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
Prescrire Int; 2005 Oct; 14(79):180-6. PubMed ID: 16285075
[TBL] [Abstract][Full Text] [Related]
7. Spironolactone for heart failure.
Med Lett Drugs Ther; 1999 Sep; 41(1061):81-2. PubMed ID: 10505071
[No Abstract] [Full Text] [Related]
8. Aldosterone antagonists in congestive heart failure.
Soberman J; Chafin CC; Weber KT
Curr Opin Investig Drugs; 2002 Jul; 3(7):1024-8. PubMed ID: 12186262
[TBL] [Abstract][Full Text] [Related]
9. Aldosterone and spironolactone in heart failure.
Weber KT
N Engl J Med; 1999 Sep; 341(10):753-5. PubMed ID: 10471464
[No Abstract] [Full Text] [Related]
10. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study.
Juurlink DN; Mamdani MM; Lee DS; Kopp A; Austin PC; Laupacis A; Redelmeier DA
N Engl J Med; 2004 Aug; 351(6):543-51. PubMed ID: 15295047
[TBL] [Abstract][Full Text] [Related]
11. An approach to heart failure and diabetes mellitus.
Fonarow GC
Am J Cardiol; 2005 Aug; 96(4A):47E-52E. PubMed ID: 16098844
[TBL] [Abstract][Full Text] [Related]
12. [Inhibition of renin-angiotensin-aldosterone system: what evidence?].
Mota T
Rev Port Cardiol; 2001 Mar; 20 Suppl 3():13-5. PubMed ID: 11409069
[TBL] [Abstract][Full Text] [Related]
13. New strategies for treatment of heart failure with aldosterone antagonists and the risk of hyperkalaemia.
Cruz CS; Cruz LS; Domingues GS; Souza CA
Expert Opin Drug Saf; 2005 Jul; 4(4):677-88. PubMed ID: 16011447
[TBL] [Abstract][Full Text] [Related]
14. Determinants of increased angiotensin II levels in severe chronic heart failure patients despite ACE inhibition.
van de Wal RM; Plokker HW; Lok DJ; Boomsma F; van der Horst FA; van Veldhuisen DJ; van Gilst WH; Voors AA
Int J Cardiol; 2006 Jan; 106(3):367-72. PubMed ID: 16337046
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone blockade over and above ACE-inhibitors in patients with coronary artery disease but without heart failure.
Shah NC; Pringle S; Struthers A
J Renin Angiotensin Aldosterone Syst; 2006 Mar; 7(1):20-30. PubMed ID: 17083070
[TBL] [Abstract][Full Text] [Related]
16. Eplerenone: new drug. Recent myocardial infarction with heart failure: a spironolactone me too.
Prescrire Int; 2006 Apr; 15(82):46-9. PubMed ID: 16604728
[TBL] [Abstract][Full Text] [Related]
17. Under-utilization of evidence-based drug treatment in patients with heart failure is only partially explained by dissimilarity to patients enrolled in landmark trials: a report from the Euro Heart Survey on Heart Failure.
Lenzen MJ; Boersma E; Reimer WJ; Balk AH; Komajda M; Swedberg K; Follath F; Jimenez-Navarro M; Simoons ML; Cleland JG
Eur Heart J; 2005 Dec; 26(24):2706-13. PubMed ID: 16183692
[TBL] [Abstract][Full Text] [Related]
18. Neurohormones and heart failure: the importance of aldosterone.
Odedra K; Ferro A
Int J Clin Pract; 2006 Jul; 60(7):835-46. PubMed ID: 16846401
[TBL] [Abstract][Full Text] [Related]
19. [Blocking of aldosterone receptors reduces the risk of events in patients with severe cardiac failure].
Opasich C
Ital Heart J Suppl; 2000 Mar; 1(3):425-6. PubMed ID: 10815276
[No Abstract] [Full Text] [Related]
20. Which inhibitor of the renin-angiotensin system should be used in chronic heart failure and acute myocardial infarction?
McMurray JJ; Pfeffer MA; Swedberg K; Dzau VJ
Circulation; 2004 Nov; 110(20):3281-8. PubMed ID: 15545527
[No Abstract] [Full Text] [Related]
[Next] [New Search]
